iBio, Inc.
Ticker: 1420720
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY26 | Q1 FY26 | Q2 FY25 | Q2 FY25 | Q1 FY24 | Q1 FY24 | Q3 FY22 | Q3 FY22 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.10+0.0% | 0.10-50.0% | 0.20+0.0% | 0.20+300.0% | 0.05+0.0% | 0.05-97.2% | 1.80-7.2% | 1.94 |
| Total Income | 0.10+0.0% | 0.10-50.0% | 0.20+0.0% | 0.20+300.0% | 0.05+0.0% | 0.05-97.2% | 1.80-7.2% | 1.94 |
| EXPENSES | ||||||||
| Expenditure | 6.05+0.0% | 6.05+31.0% | 4.62+0.0% | 4.62-10.3% | 5.15+0.0% | 5.15-40.0% | 8.59-39.2% | 14.13 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| PROFIT | ||||||||
| Net Profit | -5.72+0.0% | -5.72-31.2% | -4.36+0.0% | -4.36+24.2% | -5.75-13.4% | -5.07+59.1% | -12.39+0.0% | -12.39 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.11+0.0% | -0.11+77.1% | -0.48+0.0% | -0.48+90.0% | -4.80-1900.0% | -0.24+83.1% | -1.42-2266.7% | -0.06 |
Corporate Events
Board MeetingIBIO
202614Oct
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify au…
SEC Filing ↗ Board MeetingIBIO
20264Aug
Board Meeting
Appointment of Molly Carr, M.D., as Chief Medical Officer. …
SEC Filing ↗ Board MeetingIBIO
20267May
Board Meeting
Dr. Elizabeth Stoner appointed as a Class II director and me…
SEC Filing ↗